Evaluation of serum TWEAK levels and treatment response in psoriasis and psoriatic arthritis: a prospective comparative case–control study of adalimumab and methotrexate - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of Serum TWEAK Levels and Treatment Outcomes in Psoriasis and Psoriatic Arthritis: A Prospective Comparative Study of Adalimumab versus Methotrexate

  • By

  • Eisa M. Hegazy

  • Eslam Abdelfattah Sadek

  • Shimaa Saber Ahmed

  • March 18, 2026

Share

Original Source(s)

Evaluation of serum TWEAK levels and treatment response in psoriasis and psoriatic arthritis: a prospective comparative case–control study of adalimumab and methotrexate

  • by Eisa M. Hegazy, Eslam Abdelfattah Sadek, Shimaa Saber Ahmed

  • March 18, 2026

Related Content

Case report : Early-Onset Juvenile Psoriatic Arthritis Presenting at 15 Months: A Diagnostic Challenge in Infancy

He Needs an Expensive Drug. A Copay Card Helped — Until It Didn’t. - KFF Health News

Associations of Lifestyle-Related Factors and Psoriatic Arthritis Disease Activity: The Dutch South West Psoriatic Arthritis Study